Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
Clinical trial NCT05475665 · COMPLETED
Trial details
- NCT number
- NCT05475665
- Sponsor
- Handok Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-14
- Primary completion
- 2023-03-30
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.